Virology News and Research

Latest Virology News and Research

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase 1a clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus infection.

10 Feb 2011

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2010.

10 Feb 2011

Vical 2010 net loss increases to $30.4 million

Vical Incorporated today reported financial results for the year ended December 31, 2010. Vical had cash and investments of approximately $61 million at year-end 2010. The company received approximately $37 million of net proceeds from the sale of equity securities during 2010.

10 Feb 2011

Avian flu vaccine stockpiled in 2004 still useful

A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.

10 Feb 2011

Global Hygiene Council: Three simple steps to keep your family protected against infections

The Global Hygiene Council, a group of leading health and hygiene experts from around the world, convened in collaboration with the Centers for Disease Control and Prevention to discuss how proper hygiene plays a critical role in preventing the spread of illness and improving health around the world.

10 Feb 2011

HIV-negative babies born to HIV-positive mothers have lower antibody levels for some infections, study finds

"Babies who are exposed to HIV at birth but don't become infected with the virus have lower levels of antibodies to diseases such as whooping cough, tetanus and pneumococcus," according to a study published in the Feb. 9 issue of the Journal of the American Medical Association (JAMA), HealthDay News/U.S. News & World Report.

10 Feb 2011

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

"No one denies" that the oral polio vaccine "has considerable merits. It's cheap to make. It's easy to administer; you don't need a trained nurse with a clean syringe [like the inactive vaccine needs], just a volunteer with a dropper. And it gives excellent immunity. ... But there are problems with the method," Wendy Orent, author of the book Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease, writes in a Los Angeles Times opinion piece.

10 Feb 2011

First Edition: February 9, 2011

Today's headlines include news about GOP plans to defund the health law and stepped up Capitol Hill activity surrounding the abortion issue.

9 Feb 2011

Improved awareness of AIDS deaths, fear of infection lead to huge decline in Zimbabwe's HIV rates

The big drop in the numbers of people infected with HIV in Zimbabwe is because of mass social change, driven by fear of infection, according to an international study reported today in the journal PLoS Medicine. The scientists unravelling the reasons behind this unexpected downturn now reveal what they hope are the most important lessons in the fight against the disease for the rest of Africa.

9 Feb 2011

Vical announces issuance of US patent for HSV-2 vaccine

Vical Incorporated announced today the issuance of U.S. Patent No. 7,879,339, assigned to Vical and the University of Washington, covering DNA vaccines for herpes simplex virus type 2.

9 Feb 2011

Medicago granted FDA clearance for clinical development of seasonal flu vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received Food and Drug Administration ("FDA") clearance for its phase I H1N1 influenza VLP vaccine candidate ("H1N1 vaccine") clinical trial in the United States.

9 Feb 2011

Anti-cancer shots for boys in the pipeline

The Pharmaceutical Benefits Advisory Committee (PBAC) is deciding on whether to include the human papillomavirus (HPV) vaccine, Gardasil in in the National Immunization Program for boys.

8 Feb 2011

Total flu cover with one shot

In a medical breakthrough, English scientists have developed a so-called “universal” vaccine to influenza - one that protects against all strains of the potentially deadly illness. This would do away with the need for a new vaccine each flu season they say. Seasonal flu affects up to 20 percent of the population and kills an average of 24,600 people each year. This vaccine would act against swine flu as well assure researchers.

8 Feb 2011

International research team receives AACR award for innovative, meritorious science

The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human papillomavirus for more than 20 years.

8 Feb 2011

Elan 2010 total revenue increases 5% to $1,169.7 million

Elan Corporation, plc today reported its fourth quarter and full-year 2010 financial results and provided financial guidance for 2011.

8 Feb 2011

Anthem Blue Cross reminds seniors in Maine to get vaccinated against annual flu, pneumonia

While the seasonal flu can be very serious for patients of any age, senior citizens are particularly vulnerable. That's why Anthem Blue Cross and Blue Shield in Maine is reminding seniors across the state to get their annual flu and pneumonia vaccinations.

8 Feb 2011

Virology News and Research

Latest Virology News and Research

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

Vical 2010 net loss increases to $30.4 million

Avian flu vaccine stockpiled in 2004 still useful

Global Hygiene Council: Three simple steps to keep your family protected against infections

HIV-negative babies born to HIV-positive mothers have lower antibody levels for some infections, study finds

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

First Edition: February 9, 2011

Improved awareness of AIDS deaths, fear of infection lead to huge decline in Zimbabwe's HIV rates

Vical announces issuance of US patent for HSV-2 vaccine

Medicago granted FDA clearance for clinical development of seasonal flu vaccine

Anti-cancer shots for boys in the pipeline

Total flu cover with one shot

International research team receives AACR award for innovative, meritorious science

Elan 2010 total revenue increases 5% to $1,169.7 million

Anthem Blue Cross reminds seniors in Maine to get vaccinated against annual flu, pneumonia

New study shows economic burden of dengue in Western Hemisphere is $2.1 billion per year

Researchers develop new method for drug discovery using math to combat HIV, other diseases

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Microplate-based assays in virology research eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting